Does OXALIPLATIN Cause Tumour marker increased? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Tumour marker increased have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.0% of all adverse event reports for OXALIPLATIN.
25
Reports of Tumour marker increased with OXALIPLATIN
0.0%
of all OXALIPLATIN reports
2
Deaths
6
Hospitalizations
How Dangerous Is Tumour marker increased From OXALIPLATIN?
Of the 25 reports, 2 (8.0%) resulted in death, 6 (24.0%) required hospitalization, and 2 (8.0%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does OXALIPLATIN Cause?
Diarrhoea (4,963)
Nausea (4,250)
Neuropathy peripheral (3,662)
Off label use (3,603)
Neutropenia (3,391)
Vomiting (3,383)
Disease progression (3,370)
Thrombocytopenia (2,886)
Dyspnoea (2,779)
Pyrexia (2,269)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which OXALIPLATIN Alternatives Have Lower Tumour marker increased Risk?
OXALIPLATIN vs OXAPROZIN
OXALIPLATIN vs OXAZEPAM
OXALIPLATIN vs OXCARBAZEPINE
OXALIPLATIN vs OXITRIPTAN
OXALIPLATIN vs OXOMEMAZINE